• OPEN AN ACCOUNT
Indian Indices
Nifty
21,957.50 -345.00
(-1.55%)
Sensex
72,650.22 246.05
( 0.34%)
Bank Nifty
47,487.90 -533.20
( -1.11%)
Nifty IT
33,205.85 -129.30
( -0.39%)
Global Indices
Nasdaq
16,346.27 43.51
(0.27%)
Dow Jones
39,387.76 331.37
(0.85%)
Hang Seng
18,537.81 223.95
(1.22%)
Nikkei 225
38,073.98 -128.39
(-0.34%)
Forex
USD-INR
83.47 0.00
(-0.01%)
EUR-INR
89.79 -0.06
(-0.07%)
GBP-INR
104.34 -0.31
(-0.29%)
JPY-INR
0.54 0.00
(-0.73%)

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
531752
INE703D01023
0.8537603
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
56.5
73.74
EPS(TTM)
Face Value()
Div & Yield %
0.02
1
0
 

IIFL Finance announces commencement of special audit as per RBI directives
Apr 24,2024
IIFL Finance announced that the special audit directed by the Reserve Bank of India (RBI) has commenced as of 23 April 2024.

This follows the RBI's embargo dated 04 March 2024 which suspended the disbursement of new gold loans by our company until the satisfactory completion of the said audit. This measure was part of RBI's supervisory action over concerns related to certain loan disbursement practice.